Results 141 to 150 of about 2,525 (153)
Some of the next articles are maybe not open access.
Journal of Antimicrobial Chemotherapy
Abstract Background Extracorporeal membrane oxygenation (ECMO) is a life-saving modality but has the potential to alter the pharmacokinetics (PK) of antimicrobials. Imipenem/cilastatin/relebactam is an antibiotic with utility in treating certain multi-drug resistant Gram-negative infections.
Andrew J Fratoni +4 more
openaire +2 more sources
Abstract Background Extracorporeal membrane oxygenation (ECMO) is a life-saving modality but has the potential to alter the pharmacokinetics (PK) of antimicrobials. Imipenem/cilastatin/relebactam is an antibiotic with utility in treating certain multi-drug resistant Gram-negative infections.
Andrew J Fratoni +4 more
openaire +2 more sources
Imipenem/cilastatina/relebactam en infecciones por bacterias gramnegativas
Panorama Actual del MedicamentoRelebactam es un nuevo inhibidor de betalactamasas con estructura no betalactámica, con capacidad para inhibir betalactamasas de tipo A y C, pero no B y D. Sin actividad antibacteriana significativa, la función de relebactam en la combinación con imipenem y cilastatina consiste en restituir la actividad bactericida de imipenem cuando ésta se ve ...
openaire +1 more source
Journal of the American Pharmacists Association, 2020
Daniel A, Hussar, Elias B, Chahine
openaire +2 more sources
Daniel A, Hussar, Elias B, Chahine
openaire +2 more sources
Summary of opinion: Recarbrio,imipenem / cilastatin / relebactam
Case Medical Research, 2019openaire +2 more sources